Evidence map›Paper›PMID 41474164›Full record

ArticleMicrobiology spectrum2026

Diagnostic accuracy of self-collected anterior nasal swabs for SARS-CoV-2 RT-PCR testing.

T Corocher, K Edwards, Y Hersusianto, D Campbell, P Monagle, P Ho, INHERIT Trial Group

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

T CorocherNorthern Clinical Diagnostics & Thrombovascular Research (NECTAR) Centre, Northern Health, Melbourne, Victoria, Australia.ORCID 0000-0003-1127-0500
K EdwardsNorthern Clinical Diagnostics & Thrombovascular Research (NECTAR) Centre, Northern Health, Melbourne, Victoria, Australia.ORCID 0000-0002-8169-5187
Y HersusiantoNorthern Clinical Diagnostics & Thrombovascular Research (NECTAR) Centre, Northern Health, Melbourne, Victoria, Australia.
D CampbellHospitals without walls, Northern Health, Melbourne, Victoria, Australia.ORCID 0009-0006-2639-7001
P MonagleDepartment of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-3970-8984
P HoNorthern Clinical Diagnostics & Thrombovascular Research (NECTAR) Centre, Northern Health, Melbourne, Victoria, Australia.ORCID 0000-0003-1875-3927
INHERIT Trial Group

Funding

Victoria State Government Department of Jobs, Skills, Industry and Regions
6 · The paper itself

Abstract

This prospective sub-study aimed to compare the diagnostic accuracy of the self-collected anterior nasal swab (ANS; Rhinoswab) against that of healthcare professional (HCP)-collected combined throat and nasal swab (CTN). Eligibility criteria for the study included: >5 years of age, a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapid antigen or PCR <72 h prior, and one other participating household member. Samples were tested via reverse transcription polymerase chain reaction (RT-PCR) and included in the analysis where RS and CTN swab were collected on the same day. Indeterminate results were excluded from the analysis. Sensitivity and specificity were used to assess the accuracy of results from self-collected RS. Analysis of the average cycle threshold (Ct) was performed in GraphPad Prism using a paired IMPORTANCE: In this study, we compared the PCR results of self-collected anterior nasal swabs against healthcare professional-collected combined throat and nasal swabs. The sensitivity and specificity of the anterior nasal swab were considered acceptable when compared to World Health Organization recommendations. The sensitivity of the Rhinoswab ANS was higher at the beginning of the trial when compared with the final day of the trial, regardless of the number of prongs tested via PCR. The self-collected Rhinoswab is a valid tool for community screening of severe acute respiratory syndrome coronavirus 2 in vulnerable populations.

Indexed as

COVID-19COVID-19 Nucleic Acid TestingCOVID-19 TestingNoseSARS-CoV-2Specimen HandlingAdultAgedFemaleHealth PersonnelHumansMaleMiddle AgedPharynxProspective StudiesSensitivity and SpecificityCTNINHERITIntranasal Heparin Trialnurse-collectedRhinomedRhinoswabSARS-CoV-2self-collected

Identifiers

PMID41474164
PMCPMC12889086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.